Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Josep Balaña"'
Autor:
Francesco Sanguedolce, Gemma Sancho Pardo, Asier Mercadé Sanchez, Josep Balaña Lucena, Francesca Pisano, Julio Calderón Cortez, Angelo Territo, Jordi Huguet Perez, Josep Gaya Sopeña, Cristina Esquina Lopez, Alberto Breda, Joan Palou Redorta
Publikováno v:
Prostate International, Vol 9, Iss 1, Pp 48-53 (2021)
Background: Late onset of radiation-induced haemorrhagic cystitis (RHC) after radiation therapy (RT) for prostate cancer (PCa) may present or evolve severely, requiring hospitalization with invasive interventions. In the present study, we have analys
Externí odkaz:
https://doaj.org/article/a09159ac548c4762add1b7c272106547
Autor:
Esteban Emiliani, Andres Koey Kanashiro, Josep Balaña, Sofía Fontanet, Julia Aumatell, Julio Calderón-Cortez, Juan Iregui-Parra, Antoni Sanchez-Pui, Francisco Sanchez-Martin, Felix Millan, Oriol Angerri
Publikováno v:
Urolithiasis. 51
Autor:
Iacopo Meneghetti, Morena Turco, Angelo Territo, Alberto Breda, Francesco Sanguedolce, Davide Vanacore, Josep Balaña Lucena, Julio Calderón Cortez, Joan Palou Redorta, Josep M Gaya, Matteo Fontana, A. Gallioli
Publikováno v:
Journal of endourology. 35(11)
Introduction: Appropriate risk stratification and complete tumor ablation are the key factors to optimize the oncologic outcomes of patients undertaking endoscopic management for upper urinary trac...
Autor:
Francesco Sanguedolce, Iacopo Meneghetti, Giulio Bevilacqua, Benjamin Montaño, Christian Martínez, Angelo Territo, Josep Balaña, Joan Palou, Alberto Breda
Publikováno v:
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Introduction & Objectives: Radiation-induced haemorrhagic cystitis (RHC) is a frightening complication occurring after pelvic radiotherapy (PRT) which may significantly affect patients' quality of life. Bladder instillation with glycosaminoglycan rep